Zhao Lijun, Cao Jianzhong, Hu Kexin, He Xiaodong, Yun Dou, Tong Tanjun, Han Limin
1Peking University Research Center on Aging, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Beijing, China.
2Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Aging Dis. 2020 Jul 23;11(4):927-945. doi: 10.14336/AD.2019.0820. eCollection 2020 Jul.
Sirtuins, initially described as histone deacetylases and gene silencers in yeast, are now known to have many more functions and to be much more abundant in living organisms. The increasing evidence of sirtuins in the field of ageing and age-related diseases indicates that they may provide novel targets for treating diseases associated with aging and perhaps extend human lifespan. Here, we summarize some of the recent discoveries in sirtuin biology that clearly implicate the functions of sirtuins in the regulation of aging and age-related diseases. Furthermore, human sirtuins are considered promising therapeutic targets for anti-aging and ageing-related diseases and have attracted interest in scientific communities to develop small molecule activators or drugs to ameliorate a wide range of ageing disorders. In this review, we also summarize the discovery and development status of sirtuin-targeted drug and further discuss the potential medical strategies of sirtuins in delaying aging and treating age-related diseases.
沉默调节蛋白最初在酵母中被描述为组蛋白脱乙酰酶和基因沉默子,现在已知它们具有更多功能,并且在生物体中更为丰富。沉默调节蛋白在衰老和与年龄相关疾病领域的证据越来越多,这表明它们可能为治疗与衰老相关的疾病提供新的靶点,甚至可能延长人类寿命。在这里,我们总结了沉默调节蛋白生物学领域的一些最新发现,这些发现清楚地表明了沉默调节蛋白在衰老和与年龄相关疾病调控中的功能。此外,人类沉默调节蛋白被认为是抗衰老和与衰老相关疾病的有前景的治疗靶点,并已引起科学界对开发小分子激活剂或药物以改善各种衰老疾病的兴趣。在本综述中,我们还总结了靶向沉默调节蛋白药物的发现和开发现状,并进一步讨论了沉默调节蛋白在延缓衰老和治疗与年龄相关疾病方面的潜在医学策略。